The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke

Cerebrovascular Diseases

Volumn 27, Issue 2, 2009, Pages 131-137

  Pawelczyk, Malgorzata ^a   Baj, Zbigniew ^a   Chmielewski, Henryk ^a   Kaczorowska, Beata ^a   Klimek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hyperlipidemia; P selectin; Platelet activation; Platelet derived microparticles; sP selectin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD61 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PIRACETAM; THROMBIN; VINPOCETINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOWMETER; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; NEUROPROTECTION; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; INTEGRIN BETA3; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; STROKE;

EID: 56849092320     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000177920     Document Type: Article

References (30)

1. Milionis J, Elisaf MS, Mikhailidis DP: Platelet function and lipid-lowering interventions. Platelets 1999;10:357-367.
2. + antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolaemia. Circulation 1997;95:1370-1375.
3. Larsen E, Celi A, Gilbert GE, et al: PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-312.
4. Nomura S: Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001;74:397-404.
5. Michelson AD, Barnard MR, Hechtman HB, et al: In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11877-11882.
6. Paciaroni M, Hennerici M, Agnelli G, et al: Statins and stroke prevention. Cerebrovasc Dis 2007;24:170-182.
7. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
8. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
9. Blann AD, Nadar SK, Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003;24:2166-2179.
10. Sener A, Ozsavci D, Oba R, Demirel GY, Uras F, Yardimci KT: Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia? Clin Biochem 2005;38:1081-1087.
11. Ferroni P, Basili S, Vieri M, et al: Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia. Haemostasis 1999;29:277-285.
12. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD: Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-13840.
13. Parissis JT, Venetsanou KF, Mentzikof DG, et al: Plasma levels of soluble cellular adhesion molecules in patients with arterial hypertension: correlations with plasma endothelin-1. Eur J Intern Med 2001;12:350-356.
14. Davi G, Romano M, Mezzetti A, et al: Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998;97:953-957.
15. Marquardt L, Ruf A, Mansmann U, et al: Course of platelet activation markers after ischemic stroke. Stroke 2002;33:2570-2574.
16. Yip HK, Liou CW, Chang HW, et al: Link between platelet activity and outcomes after an ischaemic stroke. Cerebrovasc Dis 2005;20:120-128.
17. Cha JK, Jo WS, Shin HC, Bae HR, Ho JM, Kim JW: Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke. Platelets 2004;15:3-7.
18. Konstantopoulos K, Grotta JC, Sills C, Wu KK, Hellums JD: Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost 1995;74:1329-1334.
19. Cha JK, Jeong MH, Jang JY, et al: Serial measurements of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis 2003;16:376-382.
20. Ross R: Atherosclerosis is an inflammatory disease. N Engl J Med 1999;340:115-126.
21. Malle E, Sattler W: Platelets and the lipoproteins: native, modified and platelet modified lipoproteins. Platelets 1994;5:70-83.
22. Relou IA, Hackeng CM, Akkerman JW, Malle E: Low-density lipoprotein and its effect on human blood platelets. Cell Mol Life Sci 2003;60:961-971.
23. Nomura S, Inami N, Iwasaka T, Liu Y: Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole. Platelets 2004;15:167-172.
24. Nomura S, Suzuki M, Katsura K, et al: Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235-240.
25. Cherian P, Hankey GJ, Eikelboom JW, et al: Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003;34:2132-2137.
26. Lee YJ, Jy W, Horstman LL, et al: Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993;72:295-304.
27. McGregor L, Martin J, McGregor JL: Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Biosci 2006;1:830-837.
28. Friend M, Vucenik I, Miller M: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003;326:82-83.
29. Szczeklik A, Musial J, Undas A, et al: Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996;16:948-954.
30. Garlichs CD, Kozina S, Fateh-Moghadam S, et al: Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003;34:1412-1418.